Chinese participants
Showing 1 - 25 of >10,000
COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)
Active, not recruiting
- COVID-19 Respiratory Infection
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 10, 2023
Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)
Not yet recruiting
- Healthy Volunteers
- ABBV-903
- Placebo for ABBV-903
- (no location specified)
Aug 21, 2023
Healthy Volunteers Trial in Grayslake (Lutikizumab Dose A, Lutikizumab Dose B)
Recruiting
- Healthy Volunteers
- Lutikizumab Dose A
- Lutikizumab Dose B
-
Grayslake, IllinoisAcpru /Id# 259029
Oct 4, 2023
Asthma Trial (GSK3511294)
Active, not recruiting
- Asthma
- GSK3511294
-
Hangzhou, Zhejiang, ChinaGSK Investigational Site
Oct 21, 2022
Healthy Trial in Guangzhou (JNJ-77474462)
Not yet recruiting
- Healthy
-
Guangzhou, ChinaNanfang Hospital of Southern Medical Hospital
Aug 2, 2022
Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)
Not yet recruiting
- Advanced Solid Tumors
- Relatlimab
- Nivolumab
-
Shanghai, Shanghai, ChinaLocal Institution
Aug 10, 2022
Healthy Trial in Beijing (First Test Concor (Fasted), First Reference Concor (Fasted), First Test Concor (Fed))
Recruiting
- Healthy
- First Test Concor (Fasted)
- +3 more
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University-Drug Cli
Jun 26, 2023
Oral Upadacitinib Tablets to Assess Adverse Events and Change in
Not yet recruiting
- Atopic Dermatitis (AD)
- (no location specified)
Jul 17, 2023
Healthy Participants Trial in Shanghai (PF-07321332/ritonavir)
Completed
- Healthy Participants
-
Shanghai, Shanghai, ChinaHuashan Hospital,Fudan University
Jun 28, 2022
DLBCL Trial (Polatuzumab Vedotin)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- Polatuzumab Vedotin
- (no location specified)
Jul 12, 2023
Trastuzumab Emtansine as Therapy in Chinese HER2 Positive
Not yet recruiting
- Breast Cancer
- Trastuzumab emtansine
- (no location specified)
Jul 13, 2023
Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)
Completed
- Healthy Participant
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 11, 2023
Solid Tumors Trial in Shanghai City (Ipatasertib)
Active, not recruiting
- Solid Tumors
-
Shanghai City, ChinaFudan University Shanghai Cancer Center
Jan 8, 2023